» Articles » PMID: 38249681

Synthesis and Biological Evaluation of Novel 2-morpholino-4-anilinoquinoline Derivatives As Antitumor Agents Against HepG2 Cell Line

Overview
Journal RSC Adv
Specialty Chemistry
Date 2024 Jan 22
PMID 38249681
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer is a life-threatening illness all over the world, and developing anticancer treatments with high efficacy and low side effects remains a challenge. The quinoline ring structure has long been recognized as a flexible nucleus in the design and synthesis of physiologically active chemicals. In this study, five new 2-morpholino-4-anilinoquinoline compounds were synthesized and their biological anticancer potential against the HepG2 cell line was assessed. The compounds produced demonstrated varying responses against HepG2 cells, with compounds 3c, 3d, and 3e exhibiting the highest activity, with IC values of 11.42, 8.50, and 12.76 μM, respectively. It is a critical requirement that anticancer medications are able to selectively decrease cancer growth while not causing damage to normal cells. Compound 3e exhibited increased activity while maintaining adequate selectivity. It was also the most effective chemical against cell migration and adhesion, which could play an important role in drug resistance and cell metastasis. In total, the findings revealed good possibilities for anticancer therapy, suggesting a target for future development of anticancer medication.

Citing Articles

Synthesis, Anticancer Activity, and Molecular Docking of New 1,2,3-Triazole Linked Tetrahydrocurcumin Derivatives.

Duan M, Mahal A, Alkouri A, Wang C, Zhang Z, Ren J Molecules. 2024; 29(13).

PMID: 38998962 PMC: 11243220. DOI: 10.3390/molecules29133010.

References
1.
Sharko A, Lim C, McDermott M, Hennes C, Philavong K, Aiken T . The Inhibition of CDK8/19 Mediator Kinases Prevents the Development of Resistance to EGFR-Targeting Drugs. Cells. 2021; 10(1). PMC: 7828184. DOI: 10.3390/cells10010144. View

2.
Balaji S, Neupane R, Malla S, Khupse R, Amawi H, Kumari S . IND-2, a Quinoline Derivative, Inhibits the Proliferation of Prostate Cancer Cells by Inducing Oxidative Stress, Apoptosis and Inhibiting Topoisomerase II. Life (Basel). 2022; 12(11). PMC: 9693996. DOI: 10.3390/life12111879. View

3.
Gambacorti-Passerini C, le Coutre P, Piazza R . The role of bosutinib in the treatment of chronic myeloid leukemia. Future Oncol. 2019; 16(2):4395-4408. DOI: 10.2217/fon-2019-0555. View

4.
Ma X, Lv X, Qiu N, Yang B, He Q, Hu Y . Discovery of novel quinoline-based mTOR inhibitors via introducing intra-molecular hydrogen bonding scaffold (iMHBS): The design, synthesis and biological evaluation. Bioorg Med Chem. 2015; 23(24):7585-96. DOI: 10.1016/j.bmc.2015.11.003. View

5.
Zhou Y, Zhou Z, Chan D, Chung P, Wang Y, Chan A . The Anticancer Effect of a Novel Quinoline Derivative 91b1 through Downregulation of . Int J Mol Sci. 2022; 23(21). PMC: 9655098. DOI: 10.3390/ijms232113181. View